Dow Total Cost of Revenue increased by 2.7% to $9.15B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.2%, from $9.76B to $9.15B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -4.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.74B | $11.61B | $11.78B | $12.40B | $12.90B | $12.38B | $10.66B | $10.63B | $9.88B | $9.59B | $9.65B | $9.49B | $9.59B | $9.81B | $9.47B | $9.76B | $9.52B | $9.24B | $8.91B | $9.15B |
| QoQ Change | — | +8.1% | +1.4% | +5.3% | +4.0% | -4.0% | -13.9% | -0.3% | -7.1% | -2.9% | +0.6% | -1.6% | +1.1% | +2.3% | -3.5% | +3.1% | -2.4% | -2.9% | -3.6% | +2.7% |
| YoY Change | — | — | — | — | +20.1% | +6.6% | -9.5% | -14.3% | -23.4% | -22.5% | -9.5% | -10.7% | -2.9% | +2.3% | -1.8% | +2.9% | -0.7% | -5.8% | -5.9% | -6.2% |